Silvia Penuela – 2022 Feature Grant Recipient
This funding has enabled us to continue the promising research on targeting pannexin channels to stop communication between cells and reduce the growth and spread of glioblastoma tumours. Thanks to this funding we can support the technicians, graduate students, and expensive supplies we need to use in the lab to carry out this research.
Sylvia Cheng – 2022 Feature Grant Recipient
On behalf of my collaborating investigators and myself, I would like to express immense gratitude to all of you for supporting our research that we know will have profound impact on the practice and delivery of care for pediatric brain tumour patients across Canada.
Patrick Gunning – 2022 Feature Grant Recipient
Cancer treatment has undergone many advancements in the past decade to improve patient quality of life and to provide new and improved treatment strategies. However, there is still a lot of work to be done, with current treatment strategies succumbing to resistance, and other more rare cancers remaining undruggable.
Melanie Keats – 2022 Feature Grant Recipient
Glioblastoma (a fast-growing brain cancer) is the most common malignant brain tumor in adults. As a devastating diagnosis with a high mortality rate and rapid loss of function and independence, it is imperative to consider factors such as symptom management, maintaining independence and preserving or improving quality of life for the duration of the patients’ life.
Lisa Porter – 2022 Research Grant Recipient
This funding will allow us to dissect exciting data that has the potential to change the way that we are approaching treatment for one of the most aggressive forms of brain tumour, glioblastoma. We will focus not on the cancer cells themselves, which have eluted all treatment to date, but rather we will turn our focus to the supporting cells around the tumour.